News

Neurofilament light chain levels as a biomarker in multiple sclerosis

1703 2560 Anna Stelling, PhD

It has been previously shown that the neuronal cytoskeletal protein neurofilament light chain (NfL) is released into the blood and cerebrospinal fluid (CSF) upon neuroaxonal injury.1 Hence it was not…

read more

Do hormonal changes influence MS in women?

2400 1600 Anne Carter, MA (Cantab)

There is a paradox in multiple sclerosis (MS): females appear to be more susceptible to the disease than males, but also have a better long-term prognosis. Could this be due…

read more

A reliable blood test for Alzheimer’s disease – is it becoming a reality?

1024 683 Anna Stelling, PhD

The increasing number of patients suffering from dementia caused by Alzheimer’s disease (AD) is a significant challenge for society and requires action by healthcare professionals and researchers worldwide. One important…

read more

Speaking to Prof. Günther Deuschl – “The world is not a world of competitors, it is a world of collaborators.“

1041 1092 Anna Stelling, PhD

Even now, after having retired, Prof. Günther Deuschl’s ultimate goal is to cure patients. As an expert in movement disorders, he has contributed to this field substantially during his career.…

read more

New evidence against fluoxetine in stroke recovery

5805 3875 Anna Stelling, PhD

Stroke is a very common disease that leads to disability in around half of its survivors.1 It has been believed that fluoxetine, a selective serotonin-reuptake inhibitor (SSRI), could improve neurological…

read more

Across specialties – a study on brain complications in COVID-19 patients

5508 3672 Anna Stelling, PhD

Since December 2019, when clinicians first reported infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19), researchers have been trying to decipher the effects of the virus on…

read more

Journal watch: Trial sheds light on optimal management of brain arteriovenous malformation

6036 4024 Anna Stelling, PhD

The Background There has been longstanding uncertainty of whether medical management alone or additional interventional therapy is better for patients with a brain arteriovenous malformation that has never bled. Reports…

read more

Head impacts associated with depression and decreased cognitive function

6000 4000 Anna Stelling, PhD

Current research suggests that repetitive head impacts (RHI) resulting from contact sports, military service, domestic violence, or other sources are associated with cognitive and neuropsychiatric disorders.1 It has been proposed…

read more

CONy 2020

4896 3264 Anna Stelling, PhD

The world Congress on Controversies in Neurology (CONy) this year will take place from the 2nd until the 5th of October 2020 on a virtual platform. The congress will cover…

read more

Researchers found how ketamine works in depression – but that’s not all

6016 4016 Anna Stelling, PhD

Depression is a widely-spread disease, with over 264 million people being affected worldwide.1 For a subset of patients suffering from major depressive disorder (MDD), administering low doses of the anaesthetic…

read more
Brainwork is supported by unrestricted grants from: